Preclinical and Clinical Study of Efficacy of NAOQ19 against SARS-COV2: A Comprehensive Evaluation
Preprint
Abstract
Background: More than 6.2 million people have died already from COVID-19. Drug resistance and relapse cases from first generation therapeutics calls for development of new drugs in alternative medicine. Complementary and Alternative Medicines (CAM) that include herbal remedies and phytochemicals are usually not fully integrated into mainstream healthcare systems. The study proposes a CAM remedy, a new polyherbal formulation ‘NAOQ19’ against the SARS-CoV-2. Methods: The present study consists of invitro and invivo evaluation of NAOQ19 against SARS-CoV-2 infection. First, invitro testing of NAOQ19 anti-viral activity was carried out on three relevant cell lines: Vero E6, A549ACE2 and Huh 7.5.1 ACE2TMPRSS2. Next, animal model testing of NAOQ19 was performed in Syrian golden hamsters along with positive control Remdesivir and infection control for 3 days to determine the efficacy and safety of the formulation. Finally, a double blind randomized clinical trial with mild to moderate COVID-19 infected patients were evaluated to test the efficacy of NAOQ19 in human settings. Results: This study demonstrated a strong anti-viral (low EC50) activity in cell culture with live virus and exhibits reduced plaque forming units (high antiviral activity) in the Syrian golden hamster model. Moreover, in the clinical trials, NAOQ19 shows high efficacy demonstrating early recovery and reduced levels of inflammatory biomarkers among COVID-19 infected patients. Conclusion: This novel polyherbal formulation NAOQ19, demonstrates strong anti-viral activity in preclinical and clinical study; thereby proving its candidacy as a low-cost alternative medicine with minimal adverse effects.Keywords
This publication has 37 references indexed in Scilit:
- Analyzing the attitude of Indian citizens during the second wave of COVID-19: A text analytics studyInternational Journal of Disaster Risk Reduction, 2022
- Adverse events following COVID-19 vaccination: A systematic review and meta-analysisInternational Immunopharmacology, 2022
- The Post-COVID 19 long term surveillance study sequel to an add-on Ayurveda regimenJournal of Ayurveda and Integrative Medicine, 2022
- AYUSH-64 as an adjunct to standard care in mild to moderate COVID-19: An open-label randomized controlled trial in Chandigarh, IndiaComplementary Therapies in Medicine, 2022
- The Effect of Phytocompounds of Medicinal Plants on Coronavirus (2019-NCOV) InfectionPharmaceutical Chemistry Journal, 2022
- Multidrug resistance crisis during COVID-19 pandemic: Role of anti-microbial peptides as next-generation therapeuticsColloids and Surfaces B: Biointerfaces, 2021
- Ayurveda Rasayana as antivirals and immunomodulators: potential applications in COVID-19Environmental Science and Pollution Research, 2021
- Side Effects of Chloroquine and Hydroxychloroquine on Skeletal Muscle: a Narrative ReviewCurrent Pharmacology Reports, 2020
- Integrative approaches to antimicrobial resistanceEuropean Journal of Integrative Medicine, 2020
- The global impact of the coronavirus pandemicCytokine & Growth Factor Reviews, 2020